Company Profile

LFB USA, Inc. is a privately held biotechnology company in the Boston, Massachusetts area with headquarters and laboratories in Framingham, MA and production operations in Charlton, MA. LFB USA is a company within the LFB Group. LFB USA provides development, manufacturing and services to LFB S.A., its sister company rEVO Biologics, and other partners. 

One of the lead projects of LFB S.A. is the recombinant human Factor FVIIa (LR769) program. LFB USA is responsible for the upstream manufacturing of the recombinant protein and the Clinical and Regulatory aspects of the program. LR769 is currently being evaluated in a Phase 3 study in adults with congenital hemophilia A or B with inhibitors. 

LFB USA’s principal goal is to advance medical care by utilizing its proprietary technology to develop its own programs and assist its partners by providing a full range of services.  

LFB USA is currently looking for motivated scientific, business and healthcare professionals with an entrepreneurial spirit.

For more information about LFB USA please visit www.lfb-usa.com

Company Background

LFB USA, Inc. was formed as a subsidiary of LFB Biotechnologies in April, 2014 as the result of a carve-out of rEVO Biologics, Inc.

Biotechnology

Life Sciences

LFB USA

Jose Antonio Moreno Toscano

Lionel Murray

William Gavin

Linda Deciccio

Thomas Smith Csp

Bill Thickstun

The Leadership Team at LFB USA oversees strategic direction, organizational performance, and regulatory compliance. Comprised of high-level executives, including the CEO, COO, and senior VPs, the team ensures alignment with corporate goals, manages industrial planning and supply, and upholds quality and regulatory standards. Key responsibilities include steering major projects like the LR769 program and fostering a collaborative, innovative workplace culture.

Leadership Team

Quality and Safety Team

Operations Support

Leadership Team

About

Team members

Other teams at LFB USA

Quality and Safety Team

Operations Support